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Orbitofrontal cortexIn order to analyze functional connectivity in untreated and treated patients with schizophrenia, resting-state
fMRI data were obtained for whole-brain functional connectivity analysis from 22 ﬁrst-episode neuroleptic-
naïve schizophrenia (NNS), 61 ﬁrst-episode neuroleptic-treated schizophrenia (NTS) patients, and 60 healthy
controls (HC). Reductions were found in untreated and treated patients in the functional connectivity between
the posterior cingulate gyrus and precuneus, and this was correlatedwith the reduction in volition from the Pos-
itive and Negative Symptoms Scale (PANSS), that is in the willful initiation, sustenance, and control of thoughts,
behavior, movements, and speech, and with the general and negative symptoms. In addition in both patient
groups interhemispheric functional connectivity was weaker between the orbitofrontal cortex, amygdala and
temporal pole. These functional connectivity changes and the related symptoms were not treated by the neuro-
leptics. Differences between the patient groupswere that thereweremore strong functional connectivity links in
the NNS patients (including in hippocampal, frontal, and striatal circuits) than in the NTS patients. These ﬁndings
with a whole brain analysis in untreated and treated patients with schizophrenia provide evidence on some of
the brain regions implicated in the volitional, other general, and negative symptoms, of schizophrenia that are
not treated by neuroleptics so have implications for the development of other treatments; and provide evidence
on some brain systems in which neuroleptics do alter the functional connectivity.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Schizophrenia is a disorder often characterized by positive, cogni-
tive, and negative symptoms (Mueser and McGurk, 2004), which may
have different neurobiological bases (Rolls, 2012; Rolls et al., 2008).
The positive (psychotic or thought disorder) symptoms may include
hallucinations, delusions, and paranoia. The cognitive symptoms may
include a failure to maintain attention, and deﬁcits in short-termmem-
ory which is required to maintain attention. The negative symptoms
may include reduced emotion and motivation, including reduced
hedonia. The neuroleptic drugs, which include the phenothiazineszningl@163.com (Z. Liu).
is work.
. This is an open access article undersuch as chlorpromazine and the second generation drugs such as cloza-
pine and olanzapine, treat mainly the positive symptoms. There is little
evidence that treatment with neuroleptics substantially improves func-
tional recovery (measured for example bywhether the patient is in em-
ployment) formost peoplewith schizophrenia (Bowie et al., 2006; Insel,
2010; Milev et al., 2005). This may be partly because neuroleptic drugs
are not very effective in improving the cognitive and negative symp-
toms of schizophrenia (MacDonald and Schulz, 2009). In this study,
we aimed at identifying neurophysiological deﬁcits in schizophrenia
which are resistant to current anti-psychotic drugs. Identifying these
key deﬁcits which are present in schizophrenia, and which remain un-
treated by neuroleptics, is the fundamental approach that we take in
this paper, to help provide insights into possible targets for new therapy
for schizophrenia, whichmay help towards a better functional recovery
than is obtained currently with neuroleptic drugs.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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itating and severe disorder still remain unclear. Over the last two
decades,much neurophysiological evidence for structural and function-
al deﬁcits in the brain in schizophrenia has been developed into a
disconnectivity hypothesis (Frith, 1995). More direct evidence for the
neurophysiological disconnectivity hypothesis comes mainly from
functional Magnetic Resonance Imaging (fMRI) studies, particularly
resting-state fMRI studies (Khamsi, 2012; Smith, 2012), which have
shown widespread functional disconnectivity in distributed brain net-
works in schizophrenia. However, these studies have so far not revealed
a consistent pattern (Bluhm et al., 2007; Meyer-Lindenberg et al., 2005;
Whitﬁeld-Gabrieli et al., 2009; Zhou et al., 2007).
The reason for the inconsistency of the functional disconnectivity in
schizophrenia still remains unclear. It has been suggested that this may
be predominantly accounted for bymedication effects andmethodolog-
ical differences in functional connectivity (FC) analysis (Achard and
Bullmore, 2007; Honey et al., 2003; Pettersson-Yeo et al., 2011;
Stephan et al., 2009; Tao et al., 2013). There has been direct evidence
that dopamine receptor antagonists can alter FC and brain network pa-
rameters (Achard and Bullmore, 2007; Honey et al., 2003), suggesting
that antipsychoticsmay be amajor confounding factor in the FC analysis
in schizophrenia patients. Thus, patterns of functional disconnectivity in
neuroleptic-naïve schizophrenia (NNS) and neuroleptic-treated schizo-
phrenia (NTS) patients might be in part different due to the neuroleptic
treatment, but also partly similar owing to the limited efﬁciency of cur-
rent antipsychotics in treating all symptoms of schizophrenia (Bowie
et al., 2006; Insel, 2010; Milev et al., 2005). One of the aims of the cur-
rent investigationwas therefore to examine the common and the differ-
ent features of brain functional disconnectivity in untreated (NNS) and
neuroleptic treated (NTS) patientswith schizophrenia, and this is one of
the ﬁrst studies to perform this.
2. Methods
2.1. Participants
The participants were 22 ﬁrst-episode neuroleptic-naïve schizo-
phrenic (NNS) patients and 61 ﬁrst-episode neuroleptic-treated schizo-
phrenia (NTS) patients recruited from the Department of Psychiatry of
the Second Xiangya Hospital of Central South University, Changsha,
China. All the patients met the DSM-IV diagnostic criteria for schizo-
phrenia, Patient version (SCID-I/P) (First et al., 1996) (inclusion criteria
and clinical measures for the patients are provided in the Appendix).
The patient groups were not selected to be different, with the NNS pa-
tients recruited for the study in the outpatient department before
they were administered drugs. The symptoms of the patients were
evaluated using the Positive and Negative Symptoms Scale (PANSS)
(Kay et al., 1987) by three psychiatrists in our research team. Sixty
healthy controls (HC) were recruited from the communities of Chang-
sha, China. The inclusion and exclusion criteria for HC were the same
as those for the schizophrenic patients other than the DSM-IV diagnos-
tic criteria. Individuals with a family history of psychiatric illness among
their ﬁrst-degree relatives were excluded from the HC group.
All participants gave their written informed consent to participate in
the study after the risks and beneﬁts were discussed in detail. The study
was approved by the ethics committee of the Second Xiangya Hospital,
Central South University.
2.2. Construction and comparison of the whole-brain functional connectivity
network
After the resting-state fMRI data preprocessing (the fMRI data acqui-
sition and preprocessing are described in the Appendix), the whole
brain was parcellated into 90 regions of interest (ROIs) according to
the automated anatomical labeling (AAL) atlas (Tzourio-Mazoyer
et al., 2002) (45 regions in each hemisphere, given in Table S1 in theAppendix), and the time series were extracted in each ROI by averaging
the signals of all voxels within that region, and then linearly regressing
out the inﬂuence of headmotion and global signals. A correlationmatrix
for the functional connectivities was obtained for each subject. We cal-
culated partial correlation coefﬁcients because these remove the effect
of any common input from all other brain regions. By calculating partial
correlation coefﬁcients between all pairs of ROIs, with all the remaining
ROIs being controlling variables, a 90 × 90 correlation matrix was ob-
tained for each subject. [In more detail, we used a triplets-ROI based
partial-correlation approach to remove the mediation from third-party
regions. For an arbitrary pair of regions i and j, its partial correlation is
calculated multiple times, each time with one third party region k
(k = 1, 2,…, 90, k≠ i and k≠ j) being controlled (i.e. the mediation
from region k is removed). We call these 3 regions i, j and k a triplet
in this case. Since there are altogether 90 brain regions, there will be
88 third-party mediators for i and j (i.e. 88 triplets), and thus 88
partial-correlation coefﬁcients will be obtained for region pair i and j.
We then pick the smallest one (in amplitude) as the partial-correlation
coefﬁcient between i and j (Guo et al., 2014; Tao et al., 2013), indicating
that the largest inﬂuence among all third-party mediators is removed.]
This matrix was binarized to facilitate further statistical analyses by pro-
ducing a sparse connectivity matrix by setting to 1 all links in the matrix
with p b 0.01, and to 0 otherwise. The sparsity values of the HC, NTS and
NNS matrices produced by the use of the p b 0.01 criterion were 2.15%,
2.27%, 2.17% respectively. The use of this criterion of p b 0.01 can be sup-
ported in part because these sparsities are close to those of the sparsity of
brain network connectivity as measured with diffusion tensor imaging
(Hagmann et al., 2008). The use of this p b 0.01 criterion is also justiﬁed
by our priorwork, which shows that the links that are signiﬁcantly differ-
ent between patient groups identiﬁed with this approach are robust to
variation of the p b 0.01 criterion within a range of 0.01–0.1 (Ji et al.,
2014). Further discussion of the approach is provided elsewhere (Cheng
et al., 2012).
2.3. Measures of functional connectivity effects
Weused a risk difference approach,widely used inmedical statistics
(Laupacis et al., 1988; Warn et al., 2002), to test whether the binarized
connectivity matrices were different between the patient and control
groups. The effect associated with a particular link can be calculated
from the following (risk difference) score (Tao et al., 2013):
Slink ¼ L
link
p
Nlinkp
− L
link
h
Nlinkh
whereSlink is the score for a particular link, Llinkh is the number of links
with a value of 1 in the population of healthy controls, Nlinkh is the total
number of healthy controls, Llinkp is the number of links with a value of
1 in the population of schizophrenics, andNlinkp is the total number of pa-
tients. A risk difference of 0 indicates that the link is equally likely to
occur in both groups, a risk difference score greater than 0 indicates
that the link is more likely to occur (i.e. to be 1) in the patient group
than in the control group, and a score less than 0 indicates that the
link is less likely to occur in the patient group. In order to obtain the sta-
tistical signiﬁcance of the score Slink for a particular link, a permutation
test was carried out (in which scores were created just on the assump-
tion that the patients and controls were randomly allocated to a group).
In brief the rationale behind our approach for establishing functional
connectivity changes is to measure the risk difference score for each
link, and to test (using a permutation test) for each patient group
which links have signiﬁcantly different risk difference scores from the
control group. We were able to validate the main ﬁndings obtained
with this risk difference statistical approach by application of a false dis-
covery rate (FDR) procedure to the whole brain 90 × 90 matrix of func-
tional connectivity correlation values; and by application of a whole
brain FDR procedure to identify link differences based on Fourier analy-
ses of the time series of the two connected brain regions, as described in
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analysis described here because patients who have not been treated
with neuroleptic drugs are rare, and although we were able to gather
21NNSpatients for this group,wewished to use ameasure thatwas po-
tentially sensitive to differences when the group size is not very large.
Having selected this measure, all the main results as part of the statisti-
cal approach were then validated by use of an FDR approach, as de-
scribed in the “Further analyses” section.
3. Results
3.1. Participant characteristics
The participant characteristics for the three groups are shown in
Table 1. There were no signiﬁcant differences as to the sex, and years
of education between the three groups. The mean age of the groups
was similar (HC = 27.2 years, NN = 24.8, NTS = 22.9 years) [though
the difference was signiﬁcant (F = 5.176, p = 0.007), with a post-hoc
test showing that the NTS group was signiﬁcantly lower in age than
the HC group only (LSD − t = 4.30, p = 0.002)]. Illness course also
showed no signiﬁcant differences between the two patient groups.
The sum scores for the different parts of the PANSS (Kay et al., 1987)
were similar for the two patient groups, with values provided in the
Table 1. Signiﬁcant differences between the two patient groups in 10
subscale scores of the PANSS (Kay et al., 1987) were present, including
delusion, hostility, stereotyped thinking, anxiety, tension, mannerisms
and posturing, uncooperativeness, poor impulse control and preoccupa-
tion (see details in Table S2). Thus, consistent with previous studies
(Kane, 1999; Rosenheck et al., 1999; Smith et al., 1996), some of the
positive symptoms were among those treated by the neuroleptics, and
many of the cognitive and negative symptoms appeared to be treated
less efﬁciently by the neuroleptic drugs.
3.2. Comparisons of functional connectivity maps between the three groups
Usingpermutation tests on the risk difference scores, 20 signiﬁcantly
altered links were identiﬁed in the NNS group and 19 in the NTS group,
compared to the HC group (Fig. 1 and Table 2).
First the four altered functional connectivity links present in both
NNS and NTS patients are considered. They are marked with rectangles
in Figs. 1 and 2.We note that negative scores reﬂect a weaker functional
connectivity link, and positive scores a stronger link, in a patient group
relative to controls, as the score reﬂects patient group — healthy con-
trols. Links with negative scores (i.e. weaker functional connectivities
in patients relative to controls) are shown in blue in Fig. 1, and stronger
links in red.
The greatest reduction in functional connectivity in bothNNS andNTS
patients compared with HC is that between the posterior cingulate gyrus
(PCG) and precuneus (PCUN) in the left hemisphere (s =−0.19 with
p = 0.02 for NNS and s =−0.24 with p = 0.002 for NTS). Since both
the PCG and PCUN are large in the human brain, to examine better the
similarities of the changes in both patient groups, source location analysesTable 1
Sociodemographic and clinical variables of healthy controls, neuroleptic-naïve and neuroleptic
Variables HC
(n = 60)
NN
(n
Sex, No. M/F 35/25 14
Age (SD), years 27.2 (6.6) 24
Education (SD), years 13.5 (3.2) 12
Course (SD), months − 12
PANSS positive sum score (SD) − 22
PANSS negative sum score (SD) − 22
PANSS general psychiatric sum score (SD) 42
PANSS sum score (SD) − 92
Note: HC, healthy controls; NNS, neuroleptic-naïve schizophrenia; NTS, neuroleptic-treated schfor the altered voxels in these two regions were performed in NNS and
NTS respectively (calculated as described in the Appendix). From Fig. 3
(panel B and C), it can be seen that the locations of the altered voxels in
the PCG and PCUN in the NNS patients were similar to those in the NTS
patients.
The correlation analyses with the symptomsmeasured in the PANSS
across all patients showed that the change in the PCG.L–PCUN.L linkwas
signiﬁcantly correlated with the disturbance of volition (r = 0.45, p =
0.002) (Table 3), as well as with some of the other general symptoms
within the PANSS, and the PANSS general and negative symptom subto-
tal scores. [Since we were speciﬁcally interested in the common altered
links in the two patient groups, to test the hypothesis that the common
functional alterations in the two patient groups are correlated with
cognitive and negative symptoms, correlation analyses were only per-
formed between the 4 common altered links in both groups of patients
and the clinical measures in the patients. This keeps the number of tests
performed down to reasonable numbers, but as a precaution only ef-
fects that were signiﬁcant at p b 0.05 with FDR correction are shown
in Table 3. These are canonical correlations between the symptoms
and the Fourier link coefﬁcients based on the time series of the two con-
nected brain regions, as described in the ‘Further analyses’ section.]
Three interhemispheric functional connections were also re-
duced in both patient groups: those between the middle temporal
pole (TPOmid) (s = −0.17 with p = 0.03 for NNS and s = −0.28
with p = 0.00 for NTS), the superior orbitofrontal cortex (ORBsup)
(s = −0.19 with p = 0.03 for NNS and s = −0.16 with p = 0.009
for NTS), and the amygdala (AMYG) (s = −0.17 with p = 0.02 for
NNS and s = 0.21 with p= 0.001 for NTS) (Fig. 2), with additional sta-
tistical analyses conﬁrming the signiﬁcant reductions in the strength of
these links after whole brain correction with FDR provided in the
‘Further analyses’ section.
As an additional check that these four links were all reduced in both
patient groups, a direct comparison of the functional maps between the
two patient groups showed no signiﬁcant differences between these
common reduced functional connections, conﬁrming that the weak-
ened PCG–PCUN link and three interhemispheric links (bilateral
ORBsup, AMYG and TPOmid) were commonly altered in both untreated
and treated patients (p N 0.05, Table 2 and Fig. S2).
The functional connectivity links that are different between the two
patents groups are now considered. Fig. 2 shows the different patterns
of altered functional connectivity in the NNS and NTS patients. [The
resting state networks (RSN) shown on the right of Fig. 2 are based on
the constructed six-community structure for the whole brain from
healthy subjects shown in Fig. S1 in the Appendix, and was constructed
using data from more than 400 healthy brains (Tao et al., 2013). These
six communities have a clear biological signiﬁcancewhich can be classi-
ﬁed as the default mode network (DMN) (RNS1), the attention network
(RSN2), the visual system (RSN3), the auditory system (RSN4), the
sensory-motor areas (RSN5), and the sub-cortical network (RSN6).]
One difference evident in Figs. 1 and 2 is that thereweremore strength-
ened functional connections in NNS patients relative to the controls,
whereas there were more weakened connections in NTS patients-treated schizophrenia patients.
S
= 22)
NTS
(n = 61)
Statistical test
F/t / χ2 p
/8 35/26 .27 .87
.8 (8.6) 22.9 (7.5) 5.18 .007
.6 (3.2) 13.5 (2.6) 1.83 .16
.3 (16.0) 18.1 (16.1) 1.4 .16
.5 (6.2) 19.0 (6.2) −1.89 .06
.7 (10.3) 21.2 (6.7) −.63 .53
.5 (14.9) 38.2 (10.5) −1.23 .23
.3 (31.8) 85.1 (20.3) −1.16 .25
izophrenia; PANSS, positive and negative syndrome scale; SD, standard deviation.
Table 2
Functional connectivity links that are different relative to controls in neuroleptic-treated (NTS) and neuroleptic-naïve (NNS) ﬁrst-episode schizophrenic patients.
Discrepant functional links in NTS patients Discrepant functional links in NNS patients
Links Score p-Value Corrln
NTS-HC
Links Score p-Value Corrln
NNS-HC
Ins.R–PUT.R −0.320 .000 −0.058 +HIP.L–PHG.R 0.358 .000 0.072
TPOmid.L–TPOmid.R −0.276 .000 −0.145 ROL.R–STG.R 0.303 .001 0.122
IFGtriang.L– IFGtriang.R −0.242 .002 −0.061 -ROL.R–INS.R −0.270 .007 −0.078
PCG.L–PCUN.L −0.239 .002 −0.063 MOG.L–IOG.L 0.265 0.01 0.073
AMYG.L–AMYG.R −0.211 .001 −0.119 +IFGoperc.R–SMG.R 0.265 .006 0.053
PreCG.L–PoCG.L −0.207 .008 −0.058 SFGdor.L–MFG.L 0.242 .005 0.119
+PreCG.L–PreCG.R −0.194 .003 −0.071 ROL.L–INS.L −0.242 .006 −0.073
-PreCG.L–IFGoperc.L 0.191 .020 0.077 +SFGmed.L–ANG.L 0.239 .018 0.048
SFGmed.L–ANG.L −0.189 .011 −0.072 MFG.R–IPL.R −0.217 .021 −0.125
+IPL.L–IPL.R −0.162 .006 −0.047 PreCG.R–SMA.R 0.211 .018 0.052
ORBsup.L–ORBsup.R −0.160 .009 −0.070 +SFGdor.R–MFG.R 0.209 .009 0.105
SOG.L–MOG.L 0.152 .015 0.079 +PAL.L–THA.L 0.208 .022 0.032
SOG.L–SOG.R −0.146 .005 −0.069 ROL.L–ROL.R −0.206 .002 −0.072
PAL.L–PAL.R −0.144 .028 −0.062 +IFGtriang.L–ORBinf.L 0.194 .029 0.064
SPG.R–IPL.R −0.143 .028 −0.024 ORBsup.L–ORBsup.R −0.192 .029 −0.078
ORBsup.L–ORBmid.L 0.136 .020 0.076 PCG.L–PCUN.L −0.191 .022 −0.070
HES.L–STG.L 0.134 .007 0.041 AMYG.L–AMYG.R −0.173 .016 −0.115
HIP.L–HIP.R −0.129 .024 −0.091 +PUT.R–PAL.R 0.171 .006 0.043
PHG.L–PHG.R −0.114 .002 −0.063 TPOmid.L–TPOmid.R −0.168 .030 −0.114
IFGoperc.L–IFGtriang.L −0.120 .002 −0.091
Note: the positive scores reﬂect a greater proportion of patients than healthy controlswith functional connectivitymore signiﬁcant than the binarization threshold (p=0.01 for the partial
correlation) for that link than controls, and negative scores a smaller proportion of patients with functional connectivitymore signiﬁcant than the binarization threshold than healthy con-
trols. The scores were calculated with the equation described in the Methods section. The signiﬁcance level for the risk difference p-value was set at p b 0.03. NTS: neuroleptic-treated
schizophrenia; NNS, neuroleptic-naïve schizophrenia The names and abbreviations of the regions of interest are shown in Table S2.
−This indicates that there were fewer (p b 0.05) binarized links (with the binarization at p b 0.01) in the NNS than in the NTS group as shown by a permutation test.
+ This indicates that there were more (p b 0.05) binarized links in the NNS than in the NTS group as shown by a permutation test.
NTS-HC shows the value of the functional connectivity (measured by the partial correlation coefﬁcients obtained from the resting state fMRI analysis) in the NTS group minus that in the
healthy control group. A negative value thus shows aweaker functional connectivity in the NTS group than in the healthy control group. NNS-HC: the same for the functional connectivity
in theNNSgroupminus that in thehealthy control group.To helpwith the interpretation, all the functional connectivity values for the links in the tablewere positive, and themean value of
the functional connectivity for the healthy controls across these links in Table 2 was 0.31 (which was the mean of the partial correlation coefﬁcients). Further, a negative risk difference
score for a patient group — HC reﬂects a lower positive functional connectivity correlation value for a link in a patient group than in the HC group.
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NNS and the NTS groups are shown by+ or− prescripts in Table 2, and
the differences are indicated in Fig. S2.
The altered functional connectivity in the NNS group was mainly in
fronto-parietal circuits and subcortical circuits (see Fig. 2A). The abnor-
mal fronto-parietal circuits were composed of three different neural
pathways, including a circuit (i.e. a set of altered connected functional
links) involving the dorsal superior frontal gyrus (SFGdor), middle
frontal gyrus (MFG), and inferior parietal lobule (IPL); a circuit involv-
ing the inferior obitofrontal cortex (ORBinf), opercular inferior frontal
gyrus (IFGoper), triangular inferior frontal gyrus (IFGtriang) and
supramarginal gyrus (SMG); and a circuit involving themedial superior
frontal gyrus (SFGmed) and angular gyrus (ANG) (see Fig. 2A). The
subcortical circuits included a striato-thalamic circuit involving the pu-
tamen (PUT), pallidus (PAL) and thalamus (THA); and a hippocampo-
parahippocampal circuit. In addition, an insula-rolandic-superior tem-
poral circuit in the auditory network, a circuit in the sensorimotor
network involving precentral gyrus (PreCG) and supplementary
motor area (SMG), and a circuit in the visual network involving middle
occipital gyrus (MOG) and inferior occipital gyrus (IOG)were also iden-
tiﬁed as discrepant in the NNS patients (see Fig. 2A).
The altered functional connectivity in the NTS group was mainly in a
prefronto-sensorimotor circuit involving IFGoper, PreCG and postcentral
gyrus (PoCG); and a sriato-insular circuit involving PUT and insula (INS)
(see Fig. 2B). Further, it is noteworthy that the abnormal interhemispheric
connectivity was more widespread and weakened in the NTS group than
the NNS group (see Fig. 2B).3.3. Further analyses
Further analyses were performed to validate the ﬁndings obtained
with the risk difference analyses performed. In particular, a falsediscovery rate (FDR) analysis (Genovese et al., 2002) was applied to
the whole brain 90 × 90 binarized correlation matrix of functional
connectivities.
For the NTS group, the majority of the links shown in Table 2 as sig-
niﬁcant in the risk difference analysis resulted in signiﬁcant effects in
the same direction with the FDR analysis with q = 0.05 (the one-
tailed signiﬁcance level given the prior hypothesis from the permuta-
tion test) for which the statistical threshold was p = 0.0260. For ex-
ample, the following links were conﬁrmed as signiﬁcantly different
between the NTS and the control groups using the FDR approach:
INS.R–PUT.R; TPOmid.L–IFGtriang.R; IFGtriang.L–IFGtriang.R; PCG.L–
PCUN.L; AMYG.L–AMYG.R; PreCG.L–PoCG.L; PreCG.L– PreCG.R; PAL.L–
PAL.R; HIP.L–HIP.R; PHG.L–PHG.R. This additional analysis thus helps
to validate some of the main conclusions of the paper, including the re-
duced functional connectivity for the PCG.L–PCUN.L link (p = 0.003 in
the FDR analysis) in the NTS patients, and some of the reduced inter-
hemispheric links including those between the two amygdalae, and
the two temporal poles.
For the FDR analysis in the NNS group the statistical threshold was
p = 0.0081 as the number of patients was smaller, but nevertheless
the functional connectivities shown in Table 2 for the NNS group that
were signiﬁcantly different from controls included the following, in
line with the risk-difference analyses: HIP.L-PHG.R; ROL.R-STG.R;
SFGdor.L-MFG.L; MFG.R-IPL.R; and IFGoperc.L- IFGtriang.L.
We performed an additional analysis to validate the identiﬁcation of
the links in Table 2 that were common between the NTS and NNS pat-
ents as being reduced relative to controls. We did this by performing a
statistical test that was whole brain corrected using FDR to identify
which links in the combined NTS and NNS groups (83 patients) were
different from the links in the controls. The FDR threshold for signiﬁ-
cance at p b 0.05 (two-tailed) across the whole brain was 0.0166, and
all four common links were more signiﬁcant than this threshold value
of signiﬁcance as follows. PCG–PCUN p = 4.18 × 10−4; AMYG.L-
Fig. 1. A. Bar plot of the risk difference scores of the functional connectivity links in NNS patients relative to healthy controls. Negative scores reﬂect weaker links and are shown in blue,
while positive scores reﬂect stronger links and are shown in red. B. The corresponding plots for the NTS patient group. Common altered links in NNS and NTS patient groups are marked
with green rectangles.
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ORBsup.R p = 0.02. Thus all four links shown as common in being re-
duced in NTS and NNS patients in Table 2 were found to be different
using a whole brain FDR correction performed on the combined NNS
andNTS groups vs controls. This is useful validation, for the links include
links relevant to the association between avolition and the PCG–PCUN
link described in the main text; and between the negative symptoms
and the AMYG.L-AMYG.R, TPOmid.L-TPOmid.R, and the ORBsup.L-
ORBsup.R links. To perform the correlations between these links and
the symptoms, the following method was used. The correlation coefﬁ-
cient between the time series for two brain regions was replaced with
a Fisher combined probability calculated across the Fourier coefﬁcients
of the correlations between the 2 time series from the two regions
being analyzed (He et al., 2015). In more detail, we converted the
170-point time series with samples every 2 s from each subject into 17
segments each 10 time-points long, and calculated the Pearson correla-
tion for each segment. The Fourier coefﬁcients of this 17-segment time se-
ries of Pearson correlations was calculated. This algorithm provides a
measure of the variation of the link correlations across the segments of
the resting state time series. The Fourier coefﬁcients that maximized thecanonical correlation with the symptoms were used. In practice, the use
of two Fourier coefﬁcients did show signiﬁcant correlations with the
symptoms for the the PCG.L–PCUN.L link, as shown in Table 3.
4. Discussion
Features of the present study are that it used awhole-brain function-
al connectivity approach, and that it compared untreated patients with
ﬁrst-episode schizophrenia (NNS), with patients with ﬁrst-episode
schizophrenia treated with neuroleptic drugs (NTS), and with controls.
First we discuss the brain functional connectivity changes that
were common to the two patient groups, involving the weakened
PCG–PCUN coupling and some weakened interhemispheric couplings,
as they are of great interest for understanding the neuropathophysiology
of schizophrenia.
The PCG (posterior cingulate gyrus) and PCUN (precuneus), broadly
knownas the key nodes in the so-called “defaultmodenetwork” (DMN)
(Buckner et al., 2008; Fransson andMarrelec, 2008), are both located in
the posteriormedial parietal area. Importantly, within this area, the PCG
and PCUN are reciprocally and strongly anatomically interconnected
Fig. 2. Panels A and B show the altered links in neuroleptic-naïve patients (NNS) and neuroleptic-treated patients (NTS) relative to the healthy controls (HC) respectively: A(1) and
B(1) show the locations of these altered links in a transverse plane of the brain; A(2) and B(2) show the locations of these altered links in six communities of resting state networks
(RSN) indifferent colors. Twenty links in theNNS andnineteen links in theNTS patientswere found to be altered. Red lines: links increased inpatients; blue lines: links reduced inpatients;
looped links are to the contralateral side. Line thickness corresponds to the score s. The common altered links in NNS and NTS patients are marked with green rectangles.
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cal basis for their functional connectivity analyzed here. Consistent
with our ﬁnding, there have been many resting-state and task-related
fMRI studies showing abnormal functions in the PCG and PCUN
(Bluhm et al., 2007; Lynall et al., 2010; Whitﬁeld-Gabrieli et al., 2009).
Our subsequent source location analysis (Fig. 3) found that the exact
voxels with altered connectivity in the PCG and PCUN in the NNS pa-
tients were quite similar to those in the NTS patients, conﬁrming that
the PCG–PCUN circuit changed commonly in the two patient groups.
Therefore, it may be inferred that the reduced functional connectivity
between PCG andPCUN, identiﬁed in both the treated anduntreated pa-
tients in the present study, has extended previous evidence that the
functional deﬁcits in the PCG–PCUN circuit are not only critical in the
pathophysiology of schizophrenia, but also are possibly resistant to cur-
rent neuroleptic drugs. Consistent with this view, the altered functional
connectivity in the default mode network in schizophrenia was not
changed by 6 weeks of antipsychotic treatment (Lui et al., 2010).
Our subsequent correlation analysis showed a signiﬁcant association
between the weakened PCG–PCUN link and the reduced volition.Disturbances of volition as measured in this investigation using the
PANSS scales include disturbances of the self-initiation, maintenance,
and control of one3s speech, thoughts, movements and behavior (Kay
et al., 1987). That is, avolition in this sense describes a disturbance of
the way in which the self is normally perceived as being involved as the
agent that initiates speech, thoughts, movements and behavior. The
precuneus and the posterior cingulate cortex have been described as
being involved in consciousness of the self, and as having high activity
when humans are engaged in self-related mental representations during
rest (Cavanna and Trimble, 2006). This evidence is consistent with and
supports ourﬁnding that functional impairments in the PCG/PCUN region
are correlated in schizophrenia with dysfunctions in the sense of self and
self-control (Northoff and Bermpohl, 2004), such as the volitional deﬁcits.
Consistent with this proposal, the volitional deﬁcits shown by patients
with damage to various parts of the cingulate gyrus have been related
to impairment of the core self (Damasio, 2000). Indeed, recent fMRI stud-
ies have revealed abnormal brain activity and reduced functional connec-
tivity in the PCG and PCUN in schizophrenic patients during self-
referential processing and the resting state (Bluhm et al., 2007; Guo
Fig. 3. Source location of the common altered links in neuroleptic-naïve and neuroleptic-treated schizophrenia patients. Panel A shows the locations of the common altered links in both
patient groups on a brain template. Panels B and C show the source locations of the altered voxels in PCG and PCUN respectively, inwhich the right column illustrates the locations for NNS
group, and the left column for theNTS group.Warm colors show is the altered voxels in the PCG and PCUN, and the blue colors show the unchanged voxels relative to healthy controls. The
center voxels in the PCG and PCUN are denoted by red dots.
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2010), providing further evidence of the ﬁnding reported here of reduced
volition associatedwith reduced functional connectivity between the PCG
and PCUN in untreated patients with schizophrenia and also in patients
treated with antipsychotics. An implication is that a treatment other
than conventional antipsychotic drugs is needed to restore the sense of
self and of control in schizophrenia. It was further found that the reduced
functional connectivity in the PCG.L–PCUN.L link was associated with
other general symptoms (including the general subtotal score of the
PANSS) and with several of the negative symptoms of schizophrenia,
but not with the positive symptom subtotal score of the PANSS
(Table 3). The same observation applies that treatments other than con-
ventional antipsychotic drugsmay be needed to treat these other general
and negative symptoms of schizophrenia (Rolls, 2012; Rolls et al., 2008).
Another important common feature of the functional alteration in the
two patient groups is the reduced interhemispheric connectivity involv-
ing bilaterally the amygdalae, orbitofrontal cortex, and temporal pole.
This is of interest, for it has beenproposed that the lateralized abnormality
in schizophrenia can be explained either by hemisphere dysfunction, or
by impaired interhemispheric coupling, leading to a failure of the domi-
nant hemisphere to over-rule non-dominant homologous areas (Annett,Table 3
Associations of clinical variables with the common altered links in both patient groups.
ROIs Clinical variables Correlation p-Value
PCG. L – PCUN.L PANSS general sum score 0.445 0.0015
PANSS negative score 0.454 0.0011
Disturbance of volition G13 0.448 0.002
Uncooperativeness G8 0.623 1.3 × 10−6
Unusual thought content G9 0.455 0.001
Lack of judgement and insight G12 0.488 0.0006
Hostility P7 0.5853 9.7 × 10−6
Note: see names and abbreviations of the region of interest in Table S1.
All the results shown were signiﬁcant with p b 0.05 after FDR corrected for multiple
comparisons.1997; Bleich-Cohen et al., 2012). Functional connectivity analyses have
demonstrated interhemispheric disconnection in the language cortex,
particularly Broca3s area in the prefrontal cortex (Bleich-Cohen et al.,
2009a; Bleich-Cohen et al., 2009b). More evidence for this long-
standing abnormal asymmetry hypothesis in schizophrenia comes from
tract-tracing and automated imaging studies, which have consistently
demonstrated the impaired integrity of white matter (WM) ﬁbers
interconnecting the two hemispheres, such as the corpus callosum (CC)
and anterior commissure (AC) (Choi et al., 2011; Highley et al., 1999;
Hulshoff Pol et al., 2004; Patel et al., 2011). In particular, the AC, which
connects between the hemispheres the amygdalae, anterior temporal
area, and the orbitofrontal cortex (Di Virgilio et al., 1999; Highley et al.,
1999), has been reported to be impaired in bothﬁber density andWM in-
tegrity by post-mortem and diffusion tensor imaging (DTI) studies in
schizophrenia (Choi et al., 2011; Highley et al., 1999). It is interesting to
note that our ﬁnding of these weakened interhemispheric couplings has
extended the evidence from anatomical disconnection to functional dis-
connection in the areas interconnected by the AC.
Furthermore, the impaired interhemispheric functional connectivity
involving the amygdalae, anterior temporal area, and the orbitofrontal
cortex may be related to the negative symptoms in schizophrenia, as
these regions are involved in emotion and motivation (Rolls, 2013,
2014a). Importantly, previous studies have suggested little effectiveness
of pharmacological treatments on the negative symptoms (Kane,
1999; Rosenheck et al., 1999; Smith et al., 1996). Thus new agents
targeting these interhemispheric uncouplings involved in emotional
and motivational processing may help towards better functional recov-
ery for patients with schizophrenia.
Taken together, these common brain alterations in the NNS and NTS
patients, in combination with their associations with volitional deﬁcits
and negative symptoms, suggest current pharmacological treatment
may have less efﬁciency on the volitional deﬁcits and negative symptoms,
and their related neurophysiological deﬁcits in the schizophrenia pa-
tients. These points thus lead us to suggest that our ﬁndings may provide
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and volitional deﬁcits and their related neurophysiological substrates in
schizophrenia.
The present study, by applying a whole-brain functional connectivity
approach, also showed different patterns of functional deﬁcits between
the untreated and treated patients, which may provide further insight
into the medication effects on the functional connectivity in the brain of
patientswith schizophrenia.We found that in the NNS patients, function-
al connectivity was increased in hippocampal (PHG-HIP) and auditory
cortical (STG) links, and in fronto-parietal circuits (the SFGdor-MFG-IPL
circuit and ORBinf-IFGoper-IFGtriang-SMG circuit) and subcortical cir-
cuits (the striato-thalamic circuit and hippocampo-parahippocampal cir-
cuit), and became closer to normal in the NTS patients (Fig. 1). The
hippocampal/temporal lobe connectivity may be related to the positive
symptoms of schizophrenia, the fronto-parietal circuits may be related
with the deﬁcits of decision-making, working memory and attention in
schizophrenia (Tan et al., 2006), and the strengthened subcortical
striato-thalamic circuit is believed to be closely related to the pathology
of schizophrenia (Menon et al., 2001) and to the effects of antipsychotic
drugs (Heinz and Schlagenhauf, 2010). These ﬁndings are consistent
with a follow-up resting-state fMRI study, in which it was found that
the abnormal frontoparietal and striatal functionswere normalized by an-
tipsychotic medication for 6 weeks (Lui et al., 2010). This restoration by
the dopamine D2 receptor blockade produced by anti-psychotic treat-
ment may facilitate the effects of GABA, and thus reduce the increased
functional connectivity found in these circuits in the untreated patients
with schizophrenia (Rolls, 2012; Rolls et al., 2008). However, although al-
tered connectivity of the superior temporal gyrus (STG) has been consis-
tently demonstrated as correlated with hallucinations in schizophrenia
(Hoffman and Hampson, 2011; Shinn et al., 2013), in the present study,
hallucinations were not different between the NNS (Mean ± SD:
3.84 ± 1.31) and NTS (Mean ± SD: 3.56 ± 1.61) patients.
However, although altered connectivity of the superior temporal
gyrus (STG) has been consistently demonstrated as correlatedwith hal-
lucinations in schizophrenia (Plaze et al., 2006; Pu et al., 2012), in the
present study, hallucinations were not different between the NNS
(Mean± SD: 3.84 ± 1.31) and NTS (Mean± SD: 3.56± 1.61) patients.
The present study applying a whole-brain functional connectivity
analysis enables us to reveal a broadly distributed dysconnectivity pat-
tern across large-scale brain networks in schizophrenia, lending further
support to the notion of a diffuse dysregulation of neural dynamics in
this disorder (Fornito et al., 2012). Our observation, that most of the in-
creased functional connectivity in the neuroleptic-naïve (NNS) patients
appears to be normalized in the neuroleptic-treated (NTS) patients, has
highlighted the important potential contribution of medication effects
to the conﬂicting ﬁndings of both increased and decreased functional
connectivity in previous studies (Pettersson-Yeo et al., 2011).Moreover,
at the brain-network level the impaired circuits in the posterior Default
Mode Network and emotion-processing system that were not inﬂu-
enced by treatment with neuroleptics may provide new drug targets
for the negative symptoms, which are not treated well with current an-
tipsychotics. Additional implications of the present study for future
studies include the following. First, our neuroleptic-treated patients
showed only a trend towards reduction of the positive symptoms com-
pared to the untreated patients, so in future studies it could be of
interest to study patients at different stages of their treatmentwith neu-
roleptics. (In the present study, 21 NTS patients had an illness duration
of less than 6 months, and 28 had an illness duration of less than
12 months. The duration of treatment of the NTS group was in the
range 2–144 weeks, with a median of 32 weeks.) Second, the clinical
symptoms of the schizophrenic patients in the present studyweremea-
suredwith the PANSS (Kay et al., 1987). The three-factor structure (Pos-
itive, Negative and General Psychopathology Symptoms) of the PANSS,
however, may need some revision. For example, for the “disturbance of
volition” included as G13, a body of evidence has suggested that this
item should be considered with the Negative symptoms (Emsley et al.,2003; Kay and Sevy, 1990; Lancon et al., 1999; Lykouras et al., 2000),
and may be similar to the “avolition” in another psychopathology as-
sessment scale SANS (Andreasen, 1982). Moreover, the description of
G13 appears to emphasize indecisiveness which may not relate only
to volitional deﬁcits but also to cognitive impairments such as disrupted
attentional control. Thus, further research on the link between volition
and PCC-PCUN functional connectivitymight incorporatemore detailed
measures of volition. Third, in the present study we were not able to
compare the effects on functional connectivity of typical and atypical
neuroleptics, as only 9 patients received ﬁrst generation (typical) anti-
psychotic medication, and this comparison might be of interest for fu-
ture studies.
In conclusion, the present study, by applying awhole-brain functional
connectivity approach, revealed decreased functional connectivity in the
precuneus–parahippocampal connectivity that was associated with the
decrease in the sense of the self being in control (decreased volition);
and a decrease in interhemispheric connectivity between temporal lobe
structures involved in emotion thatwas related to thenegative symptoms
of schizophrenia. This reduced connectivity, and the related volition and
negative symptoms, were not treated by the antipsychotic drugs used in
the NTS group. An implication is that treatments that increase this con-
nectivity, such as treatments that restore the hypoglutamatergia of
schizophrenia (Coyle, 2012; Coyle et al., 2012), might treat these symp-
toms of schizophrenia (Rolls, 2012; Rolls et al., 2008). The increased func-
tional connectivity found in hippocampal and auditory circuits may be
related to the positive symptoms of schizophrenia, and were reduced by
the antipsychotic treatment, which may have produced this change by
the D2 receptor blockadewhich can facilitate the actions of the inhibitory
transmitter GABA (Rolls, 2012; Rolls et al., 2008). In addition, the results
described here inform our basic understanding of brain structure–func-
tion relations by providing new evidence on the relation between the
precuneus and posterior cingulate gyrus and volition, understood as the
willful initiation, sustenance, and control of thoughts, behavior, move-
ments, and speech; andonhowreduced interhemispheric functional con-
nectivity between brain structures such as the amygdala, orbitofrontal
cortex, and temporal pole could be related to reductions in emotion and
motivation that relate to the negative symptoms of schizophrenia, emo-
tional withdrawal, and depression.
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Appendix
Inclusion and Exclusion Criterion for the Participants
Twenty-two neuroleptic-naïve schizophrenic patients (NNS) and
sixty-one neuroleptic-treated schizophrenia patients (NTS) were re-
cruited from the Department of Psychiatry of the Second Xiangya Hos-
pital of Central South University, Changsha, China. All participants
were diagnosed with schizophrenia using the Structural Clinical
471W. Pu et al. / NeuroImage: Clinical 6 (2014) 463–474Interview for DSM-IV, Patient version (SCID-I/P) and met the following
inclusion criteria: 1) 18-45 years of age; 2) Han Chinese ethnicity; and
3) right handedness. Participantswere excluded if they had: 1) a history
of substance-related disorders; 2) a history of neurological illness or
other serious physical illness; 3) a contraindication for MRI; or 4) a his-
tory of electroconvulsive therapy. The patients in the two groups were
similar, except that the research described here was performed in the
NNS group before treatment started.
Sixty healthy controls (HC), including 35males and 25 females, were
recruited from Changsha, China. The inclusion and exclusion criteria for
HCwere the same as those for the schizophrenic patients other than the
DSM-IV diagnostic criteria. Individualswith a family history of psychiat-
ric illness among their ﬁrst-degree relatives were excluded from the HC
group.
The PANSS (Kay et al., 1987) sum scores for the NNS vs NTS groups
showed no signiﬁcant differences, and for the PANSS positive sum
score were 22.5±6.2 vs 19.0±6.2 (mean±sd); for the PANSS negative
sum score were 22.7±10.3 vs 21.2±6.7; for the PANSS general psychi-
atric sum score were 42.4±14.9 vs 38.2±10.5; and for the PANSS sum
score were 92.3±31.8 vs 85.1±20.3). It is noted that the positive symp-
tom sum score showed a trend-level difference (t=-1.89, p=0.06) be-
tween the two patient groups.
Medication Dosage and Duration of Neuroleptic-treated Patients
All the NTS patients were taking antipsychotics at the time of scan-
ning: nine patients (15%) were receiving ﬁrst generation antipsychotics
(FGAs) (sulpiride, 7 cases; and haloperidol, 2 cases); forty two patients
(69%) were receiving second generation antipsychotics (SGAs) (cloza-
pine, 7 cases; risperidone, 19 cases; quetiapine, 10 cases; olanzapine, 6
cases), and ten patients (16%)were receiving combination therapy (com-
bining an FGA and an SGA, 4 cases; and combining an SGA and an SGA, 6
cases). All medication doses were converted to chlorpromazine equiva-
lence (50~1500 mg/day). The mean dosages of treatments with FGAs,
SGAs and combination therapy were 822.9 mg/day, 384.6 mg/day and
572.3 mg/day respectively. Moreover, the mean medication duration of
the NTS patients was 36.8 weeks (2 ~144 weeks).
Image acquisition
All subjects underwent structural and functionalMRI scanning using
the same 1.5-T GE Signa Twinspeed MR scanner (General Electric
Medical System, Milwaukee, USA). A standard head coil was used for
radio frequency transmission and reception of the nuclear magnetic res-
onance signal. Foampads and ear plugswere used tominimize headmo-
tion and scanner noise. All the subjects were instructed to keep their
eyes closed, not to think about anything in particular and to move as
little as possible. 3-D structural MRI images (T1-weighted) were ac-
quired from the sagittal plane using spoiled gradient echo (SPGR)
pulse sequence, scanning parameter: TR =12 ms, TE =4.2 ms, ﬂip
angle =15°, 172 slices, matrix size =256 × 256, and the ﬁeld of view
(FOV)=24×24 cm. Slices were contiguous with slice thickness of
1.8mm. Functional images were acquired by using a gradient-echo
echo-planar imaging sequence sensitive to BOLD signal (TR/TE =2000/
40 ms, ﬂip angle =90°, FOV =24×24 cm). Whole-brain volumes were
acquired with 20 contiguous 5mm thick transverse slices with a 1mm
gap and 3.75×3.75 mm in-plane resolution. For each subject, fMRI scan-
ning lasted for 6 minutes and 180 volumes were obtained.
Functional Imaging data preprocessing
Before preprocessing, the ﬁrst 10 volumeswere discarded to allow for
scanner stabilization and the subjects’ adaptation to the environment.
fMRI data preprocessingwas then conducted by SPM5 (University College
London, UK; http://www.ﬁl.ion.ucl.ac.uk/spm) and DPARSF (Data Pro-
cessing Assistant for resting-state fMRI). The remaining functional scanswere quickly corrected for within-scan acquisition time differences be-
tween slices, and then realigned to the middle volume to correct for
interscan head motion. Subsequently, the functional scans were spatially
normalized to a standard template (Montreal Neurological Institute)
and re-sampled to 3 × 3 × 3 mm. After normalization, the Blood Ox-
ygenation Level Dependent (BOLD) signal of each voxel was ﬁrst
detrended to remove the linear trend and then passed through a
band-pass ﬁlter (0.01-0.08 Hz) to reduce low-frequency drift and
high-frequency physiological noise. In addition to band-pass ﬁlter-
ing and correcting for movements, additional preprocessing steps,
such as global signal regression (Fox et al., 2009), were performed.
Global signal regression may lead to artefactual negative correla-
tions, but this technique was used because it is suggested to im-
prove the speciﬁcity of positive correlations and can remove
speciﬁc confounds from the data to facilitate the evaluation of neu-
rophysiological relationships, helping to make the data more readi-
ly or reliably interpretable (Fox et al., 2009). We note that there is
recent evidence that the global brain signal is altered in schizophre-
nia (Yang et al., 2014). Thus, nuisance covariates, including head
motion parameters, global mean signals, white matter signals and
cerebrospinal ﬂuid signals were regressed out from the Blood Oxy-
genation Level Dependent (BOLD) signals.
Voxel Location
In order to detect the location of the voxels in the PCG and PCUN re-
gions which show signiﬁcant differences between patients and healthy
controls (Fig. 3), Pearson correlation coefﬁcients between all pairs of
voxels of the PCG-PCUN link were ﬁrst calculated, then a Fisher’s r-to-z
transformation was utilized to convert each correlation coefﬁcient rij
into Zij to improve the normality. After Fisher’s r-to-z transformation,
two-sample t-tests were performed for all inter-voxel correlation coefﬁ-
cients. A signiﬁcance level of pb0.05wasused to specify the source voxels
within this regional link. To identify dysfunctional voxels, for each select-
ed voxel i in region A, a dysfunction intensity for this voxelwas deﬁned as
follows:
Intensity ið Þ ¼ N
B
i
NB
where NiB is the number of voxels in region B that show signiﬁcantly dif-
ferent (pb0.05) functional connectivity with the selected voxel i in region
A compared with normal controls. NB is the total number of voxels in re-
gion B. This is reasonable since the value of intensity represents the signif-
icance of the changed correlation for each voxel. An intensity level
(intensityN0.32) was further used to threshold voxels into two groups
of voxels (unchanged and changed).
Table S1
The Names and Abbreviations of the Regions of Interest (ROIs).Regions Abbr. Regions Abbr.Amygdala AMYG Orbitofrontal cortex
(middle)ORBmidAngular gyrus ANG Orbitofrontal cortex
(superior)ORBsupAnterior cingulate gyrus ACG Pallidum PAL
Calcarine cortex CAL Paracentral lobule PCL
Caudate CAU Parahippocampal gyrus PHG
Cuneus CUN Postcentral gyrus PoCG
Fusiform gyrus FFG Posterior cingulate gyrus PCG
Heschlgyrus HES Precentral gyrus PreCG
Hippocampus HIP Precuneus PCUN
Inferior occipital gyrus IOG Putamen PUT
Inferior frontal gyrus
(opercula)IFGoperc Rectus gyrus REC(continued on next page)
TF
su
472 W. Pu et al. / NeuroImage: Clinical 6 (2014) 463–474able S1 (continued)Regions Abbr.ig. S1. a. Community structure de
bject. c. (Left) Medial view of thrived from n
e surface ofRegionsormal healthy subjects (Tao et
the brain. (Right) The lateral vieAbbr.Inferior frontal
gyrus(triangular)IFGtriang Rolandic operculum ROLInferior parietal lobule IPL Superior occipital gyrus SOG
Inferior temporal gyrus ITG Superior frontal gyrus
(dorsal)
SFGdorInsula INS Superior frontal gyrus
(medial)SFGmedLingual gyrus LING Superior parietal gyrus SPG
Middle cingulate gyrus MCG Superior temporal gyrus STG
Middle occipital gyrus MOG Supplementary motor area SMA
Middle frontal gyrus MFG Supramarginal gyrus SMG
Middle temporal gyrus MTG Temporal pole (middle) TPOmid
Olfactory OLF Temporal pole (superior) TPOsup
Orbitofrontal cortex (inferior) ORBinf Thalamus THA
Orbitofrontal cortex (medial) ORBmedTable S2
Signiﬁcant Differences of PANSS Sub-scales between Neuroleptic-naïve Patients and Neu-
roleptic-treated Patients.Variables NNS (N=22) NTS (N=61)Mean SD Meanal., 2
w ofSD
Delusion score 4.8 2.0 3.7 1.4
Hostility score 2.6 1.1 1.8 1.0
Stereotyped thinking score 2.3 1.3 1.5 0.7
Anxiety score 3.4 1.3 2.6 1.1
Tension score 3.0 1.4 2.3 1.0
mannerisms and posturing score 2.7 1.5 2.0 0.9
Uncooperativeness score 2.4 1.2 1.6 0.9
Poor impulse control score 3.4 1.6 2.4 1.2
Preoccupation score 3.1 1.4 2.3 1.2Note: NNS, neuroleptic-naïve schizophrenia; NTS neuroleptic-treated schizophrenia;
PANSS, positive and negative syndrome scale; SD, standard deviation.013). b. The
the surfacecorrelation coefﬁcient matrix of the BOLD signals from 90 ROIs of one randomly selected
of the brain. Different colors represent different communities.
Fig. S2. Differences in functional connectivity maps between neuroleptic-naïve and neuroleptic-treated schizophrenia patients. The red lines indicate links strengthened in NNS patients
and blue lines indicate links weakened in NNS patients, compared to NTS patients. The line thickness indicates the difference magnitude of the connection strength between the two pa-
tient groups. The common altered links in the two patient groups shown include the precuneus-posterior cingulate cortex link, and three interhemispheric links (bilateral orbitofrontal
cortex, amygdalae and temporal pole). These links showed no signiﬁcant differences (p>0.05) between the two patient groups.
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